- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection
Patent holdings for IPC class A61P 37/06
Total number of patents in this class: 7241
10-year publication summary
|
96
|
135
|
244
|
430
|
347
|
515
|
592
|
624
|
654
|
573
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10612 |
112 |
| The Regents of the University of California | 20303 |
75 |
| Chugai Seiyaku Kabushiki Kaisha | 1379 |
53 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3374 |
52 |
| F. Hoffmann-La Roche AG | 7937 |
45 |
| Selecta Biosciences, Inc. | 191 |
42 |
| Bristol-myers Squibb Company | 4826 |
40 |
| Janssen Biotech, Inc. | 1594 |
38 |
| Genentech, Inc. | 4016 |
37 |
| Takeda Pharmaceutical Company Limited | 2721 |
36 |
| Eli Lilly and Company | 3926 |
36 |
| Regeneron Pharmaceuticals, Inc. | 4453 |
36 |
| Ono Pharmaceutical Co., Ltd. | 428 |
35 |
| Astellas Pharma Inc. | 1057 |
34 |
| Daiichi Sankyo Company, Limited | 1879 |
34 |
| Incyte Corporation | 1039 |
33 |
| The Board of Trustees of the Leland Stanford Junior University | 6541 |
32 |
| The General Hospital Corporation | 4801 |
32 |
| Osaka University | 3377 |
31 |
| The Trustees of the University of Pennsylvania | 4390 |
28 |
| Other owners | 6380 |